Journals / Van Tıp Dergisi / 2022 / Cilt: 29 - Sayı: 3

Evaluation of Prognostic Factors in our Malignant Melanoma Cases

Malign Melanom Olgularımızda Prognostik Faktörlerin Değerlendirilmesi

Pages
254–259
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In melanoma, early diagnosis seriously affects the prognosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Melanomas are neoplasms that usually develop on the skin with a high prevalence and a mortality rate that is increasing year by year.
📊
Key Findings & Data:Studies reflecting the data of this neoplasm, which has a very high mortality rate in our country, are still limited today.
💡
Conclusion & Impact:In melanoma, early diagnosis seriously affects the prognosis.
🔬Design:Research Article
📍Scope:2010 Verileri
⚙️Variables:Domain Parameters

Abstract

Introduction: Melanomas are neoplasms that usually develop on the skin with a high prevalence and a mortality rate that is increasing year by year. Studies reflecting the data of this neoplasm, which has a very high mortality rate in our country, are still limited today. Our aim in our study was to retrospectively evaluate the skin melanoma cases treated in our hospital and to compare them with other studies. Material and Method: The clinical and histopathological features of 57 patients diagnosed with skin melanoma in the pathology clinic of our hospital between 2010 and 2019 were examined. Results: The mean age (1956) of patients was 63.1816.54 years. The lesions were located in the head and neck in 21 patients (36.8%), in the lower extremities in 16 patients (28.1%), in the upper extremities in 11 patients (19.3%) and in the trunk in 9 patients (15.8%). Metastasis developed in 9 (15.8%) patients during a minimum 1-year and maximum 10- year follow-up of our cases. In the present study, 40 patients (70.2%) were diagnosed with nodular melanoma, 8 (14%) with superficial melanoma, 2 (3.5%) with lentigo and 7 (12.3%) with acral melanoma. Discussion and Conclusion: As a result, most of our melanoma cases appeared as nodular type in the head and neck region due to sun exposure. Our study showed that these patients applied to the health institution in the late stage. In melanoma, early diagnosis seriously affects the prognosis.

Özet

Amaç: Melanom her yıl insidansı artarak giden mortalitesi oldukça yüksek ve genellikle deriden gelişen neoplazmdır.Mortalitesi oldukça yüksek olan bu neoplazma ait ülkemiz verilerin yansıtan çalışmalar günümüzde hala sınırlıdır. Biz de hastanemizde tedavi edilen deri melanom olgularını retrospektif olarak değerlendirdik ve diğer çalışmalarla karşılaştırmayı planladık. Gereç ve Yöntem: 2010-2019 yılları arasında hastanemiz patoloji kliniğinde deri melanoma tanısı almış 57 hastanın klinik ve histopatolojik özellikleri incelendi. Bulgular: Hastaların ortalama yaşı (1956) 63.1816.54’dür. Lokalizasyona göre 21 hastamız (%36.8) baş boyun, 16 hastamız (%28.1) alt ekstremite, 11 hastamız (%19.3) üst ekstremite, 9 hastamız (%15.8) gövde yerleşimlidir. Olgularımızın mínimum 1 yıllık ve maksimum 10 yıllık takiplerinde 9 (%15.8) hastada metastaz gelişti. Çalışmamızda ki 40 hasta (%70.2) nodüler melanoma, 8 hasta (%14) süperficial, 2 hasta (%3.5) Lentigo, 7 hasta (%12.3) akral melanom tanısı almıştır. Tartışma ve Sonuç: Sonuç olarak, melanomalı olgularımızın çoğunluğu güneş maruziyetine bağlı olarak baş-boyun bölgesinde ve nodüler tip olarak karşımıza çıkmıştır. Çalışmamız, bu hastaların geç evrede sağlık kuruluşuna başvurduğunu gösterdi. Melanom’da ise erken tanı prognozu ciddi olarak etkilemektedir.

🔖

Cite This Article

CENGİZ, B. P., TUĞRUL, F. (2022). Evaluation of Prognostic Factors in our Malignant Melanoma Cases. Van Tıp Dergisi, Cilt: 29 - Sayı: 3, 254–259. https://ajindex.com/articles/645880

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Cengiz BP, Tezel GG. Molecular Pathology and Carcinogenesis in Melanoma. Turkiye Klinikleri J Med Oncol-Special Topics. 2014; 7 (2): 12-17
  2. Yalçın Ö, Erdem ZB. Comparison of prognostic parameters, intratumoral mast cells and epidermal changes in malignant melanoma patients. Maltepe Med J. 2020; 12(1):11-15
  3. Melanoma of Skin. https://gco.iarc.fr/today/data/factsheets/c ancers/16-Melanoma-of-skin-fact-sheet.pdf 4. Bandarchi B, Ma L, Navab R, Seth A, Rasty G. From melanocyte to malignant melanoma. Dermatol Res Pract. 2010; 2010:583748
  4. Tronnier M, Semkova K, Wollina U, Tchernev G. Malignant melanoma: epidemiologic aspects, diagnostic and therapeutic approach. Wein Med Wochensschr. 2013; 163(15-16):354-358
  5. Mervic L. Prognostic factors in patients with localized primary cutaneous melanoma. Acta Dermatovenerol APA. 2012; 21(2):27- 31
  6. Balch CM, Murad TM, Soong SJ, Ingalls AL, Halpern NB, Maddox WA. A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark’s and Breslow’s staging methods. Ann Surg. 1978; 188:732-742
  7. Giblin AV, Thomas JM. Incidence, mortality and survival in cutaneous melanoma. J Plast Reconstr Aesthet Surg. 2007; 60(1):32-40
  8. Eser S, Yakut C, Özdemir R, Karakılınç H, Özalan S, Marshall SF, et al. Cancer incidance rates in Turkey in 2006: a detailed registry based estimation. Asian Pac J Cancer Prev. 2010; 11(6):1731-1739
  9. Purim KSM, Bonetti JPC, Silva JYF, Marques LB, Pinto MCS, Ribeiro LC. Characteristics of melanoma in the elderly. Rev Col Bras Cir. 2020; 47: e20202441
  10. Zhang M, Zhang N. Clinical and Prognostic Factors in 98 patients with malignant melanoma in China. J Int Med Res. 2017;45(4): 1369-1377
  11. Taş F, Kurul S, Camlıca H, Topuz E. Malignant Melanoma in Turkey: A single Instituon’s Experience on 475 Cases. Jpn J Clin Oncol. 2006; 36(12): 794-799
  12. Şimşek T, Sönmez A, Demir A, Tayf r V, Güneren E, Eroğlu L, ve ark. Our Clinical Experience in 84 Patients with Cutaneous Malignant Melanoma. Turk Plast Surg. 2011;19(3):113-116
  13. Şahin İ, Aykan A, Alhan D, Zor F, Öztürk S, Eski M, ve ark. Retrospective Evaluation of Malignant Melanoma Cases. Gülhane Med J. 2011; 53(3):177-181
  14. Tucker MA. Melanoma epidemiology. Hematol Oncol Clin N Am. 2009; 23(3): 383-395
  15. İbiloğlu İ, Alabalık U, Keleş AN, Aydoğdu G, Nacir M, Büyükbayram H. Retrospective Evaluation of Malignant Melanoma Cases in Diyarbakır Region. Dicle Med J. 2020; 47(2):394-403
  16. Büyükpınarbaşlı N, Dem